Helicobacter pylori virulence and cancer pathogenesis

Future Oncology

Volumn 10, Issue 8, 2014, Pages 1487-1500

  Yamaoka, Yoshio ^a,b   Graham, David Y ^b  

^a OITA UNIVERSITY   (Japan)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

CagA product; DupA; gastric cancer; genetic instability; Helicobacter pylori; inflammation associated malignancy; next generation sequencers; OipA; VacA; vacuolating cytotoxin; virulence factors

Indexed keywords

ADHESIN; CAGA PROTEIN; PROTEIN DUPA; PROTEIN OIPA; UNCLASSIFIED DRUG; VACUOLATING TOXIN; VIRULENCE FACTOR; BACTERIAL ANTIGEN; BACTERIAL PROTEIN; BACTERIAL SECRETION SYSTEM; CAGA PROTEIN, HELICOBACTER PYLORI; DUPA PROTEIN, HELICOBACTER PYLORI; OIPA PROTEIN, HELICOBACTER PYLORI; OUTER MEMBRANE PROTEIN; VACA PROTEIN, HELICOBACTER PYLORI;

ACHLORHYDRIA; ATROPHIC GASTRITIS; BACTERIAL VIRULENCE; CANCER RISK; CARCINOGENESIS; DUODENUM ULCER; EPITHELIUM CELL; FRAMESHIFT MUTATION; GASTRITIS; GENETIC POLYMORPHISM; GENOTYPE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; INTRACELLULAR SIGNALING; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENICITY ISLAND; PEPTIC ULCER; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW; STOMACH CANCER; TYPE IV SECRETION SYSTEM; BACTERIAL SECRETION SYSTEM; CELL TRANSFORMATION; COMPLICATION; GENETICS; METABOLISM; NEOPLASMS; PATHOGENICITY; VIRULENCE;

ANTIGENS, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL PROTEINS; BACTERIAL SECRETION SYSTEMS; CELL TRANSFORMATION, NEOPLASTIC; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; NEOPLASMS; VIRULENCE; VIRULENCE FACTORS;

EID: 84905216995     PISSN: 14796694     EISSN: 17448301     Source Type: Journal    
DOI: 10.2217/fon.14.29     Document Type: Review

References (93)

1. Chiba T, Marusawa H, Ushijima T. Infammation-associated cancer development in digestive organs: mechanisms and roles for genetic and epigenetic modulation. Gastroenterology 143(3), 550-563 (2012).
2. Correa P. Gastric cancer: overview. Gastroenterol. Clin. North Am. 42(2), 211-217 (2013).
3. Atherton JC, Blaser MJ. Coadaptation of Helicobacter pylori and humans: ancient history, modern implications. J. Clin. Invest. 119(9), 2475-2487 (2009).
4. Graham DY, Lu H, Yamaoka Y. African, Asian or Indian enigma, the East Asian Helicobacter pylori: facts or medical myths. J. Dig. Dis. 10(2), 77-84 (2009).
5. Lee YY, Mahendra RS, Graham DY. Helicobacter pylori infection-a boon or a bane: lessons from studies in a low-prevalence population. Helicobacter 18(5), 338-346 (2013).
6. Amieva MR, El-Omar EM. Host-bacterial interactions in Helicobacter pylori infection. Gastroenterology 134(1), 306-323 (2008).
7. Graham DY. Helicobacter pylori infection in the pathogenesis of duodenal ulcer and gastric cancer: a model. Gastroenterology 113 (6), 1983-1991 (1997).
8. Belogolova E, Bauer B, Pompaiah M et al. Helicobacter pylori outer membrane protein HopQ identifed as a novel T4SS-associated virulence factor. Cell Microbiol. 15(11), 1896-1912 (2013).
9. Ilver D, Arnqvist A, Ogren J et al. Helicobacter pylori adhesin binding fucosylated histo-blood group antigens revealed by retagging. Science 279(5349), 373-377 (1998).
10. Mahdavi J, Sonden B, Hurtig M et al. Helicobacter pylori SabA adhesin in persistent infection and chronic infammation. Science 297(5581), 573-578 (2002).
11. Oleastro M, Cordeiro R, Yamaoka Y et al. Disease association with two Helicobacter pylori duplicate outer membrane protein genes, homB and homA. Gut Pathog. 1(1), 12 (2009).
12. Shiota S, Watada M, Matsunari O et al. Helicobacter pylori iceA, clinical outcomes, and correlation with cagA: a meta-analysis. PLoS ONE 7(1), e30354 (2012).
13. Tegtmeyer N, Wessler S, Backert S. Role of the cag-pathogenicity island encoded type IV secretion system in Helicobacter pylori pathogenesis. FEBS J. 278(8), 1190-1202 (2011).
14. Backert S, Clyne M, Tegtmeyer N. Molecular mechanisms of gastric epithelial cell adhesion and injection of CagA by Helicobacter pylori. Cell Commun. Signal. 9, 28 (2011).
15. Barden S, Lange S, Tegtmeyer N et al. A helical RGD motif promoting cell adhesion: crystal structures of the Helicobacter pylori type IV secretion system pilus protein CagL. Structure 21(11), 1931-1941 (2013).
16. Kwok T, Zabler D, Urman S et al. Helicobacter exploits integrin for type IV secretion and kinase activation. Nature 449(7164), 862-866 (2007).
17. Hatakeyama M. Anthropological and clinical implications for the structural diversity of the Helicobacter pylori CagA oncoprotein. Cancer Sci. 102(1), 36-43 (2011).
18. Franco AT, Israel DA, Washington MK et al. Activation of beta-catenin by carcinogenic Helicobacter pylori. Proc. Natl Acad. Sci. USA 102 (30), 10646-10651 (2005).
19. Franco AT, Johnston E, Krishna U et al. Regulation of gastric carcinogenesis by Helicobacter pylori virulence factors. Cancer Res. 68(2), 379-387 (2008).
20. Sugimoto M, Ohno T, Yamaoka Y. Expression of angiotensin II type 1 and type 2 receptor mRNAs in the gastric mucosa of Helicobacter pylori-infected Mongolian gerbils. J. Gastroenterol. 46 (10), 1177-1186 (2011).
21. Sugimoto M, Ohno T, Graham DY, Yamaoka Y. Helicobacter pylori outer membrane proteins on gastric mucosal interleukin 6 and 11 expression in Mongolian gerbils. J. Gastroenterol. Hepatol. 26(11), 1677-1684 (2011).
22. Ohnishi N, Yuasa H, Tanaka S et al. Transgenic expression of Helicobacter pylori CagA induces gastrointestinal and hematopoietic neoplasms in mouse. Proc. Natl Acad. Sci. USA 105(3), 1003-1008 (2008).
23. Yamaoka Y. Mechanisms of disease: Helicobacter pylori virulence factors. Nat. Rev. Gastroenterol. Hepatol. 7(11), 629-641 (2010).
24. Yamaoka Y, Kodama T, Kashima K, Graham DY, Sepulveda AR. Variants of the 3' region of the cagA gene in Helicobacter pylori isolates from patients with different H. pylori-associated diseases. J. Clin. Microbiol. 36(8), 2258-2263 (1998).
25. Jones KR, Jang S, Chang J Y et al. Polymorphisms in the intermediate region of VacA impact Helicobacter pylori-induced disease development. J. Clin. Microbiol. 49(1), 101-110 (2011).
26. Vilaichone RK, Mahachai V, Tumwasorn S et al. Molecular epidemiology and outcome of Helicobacter pylori infection in Thailand: a cultural cross roads. Helicobacter. 9(5), 453-459 (2004).
27. Hirai I, Sasaki T, Kimoto A et al. Infection of less virulent Helicobacter pylori strains in asymptomatic healthy individuals in Thailand as a potential contributing factor to the Asian enigma. Microbes Infect. 12(3), 227-230 (2010).
28. Matsunari O, Shiota S, Suzuki R et al. Association between Helicobacter pylori virulence factors and gastroduodenal diseases in Okinawa, Japan. J. Clin. Microbiol. 50(3), 876-883 (2012).
29. Yamaoka Y, Reddy R, Graham DY. Helicobacter pylori virulence factor genotypes in children in the United States: clues about genotype and outcome relationships. J. Clin. Microbiol. 48(7), 2550-2551 (2010).
30. Yamaoka Y, El-Zimaity HM, Gutierrez O et al. Relationship between the cagA 3́ repeat region of Helicobacter pylori, gastric histology, and susceptibility to low pH. Gastroenterology 117(2), 342-349 (1999).
31. Selbach M, Paul FE, Brandt S et al. Host cell interactome of tyrosine-phosphorylated bacterial proteins. Cell Host Microbe 5(4), 397-403 (2009).
32. Mueller D, Tegtmeyer N, Brandt S et al. c-Src and c-Abl kinases control hierarchic phosphorylation and function of the CagA effector protein in western and east Asian Helicobacter pylori strains. J. Clin. Invest. 122 (4), 1553-1566 (2012).
33. Uchida T, Nguyen LT, Takayama A et al. Analysis of virulence factors of Helicobacter pylori isolated from a Vietnamese population. BMC Microbiol. 9, 175 (2009).
34. Xia Y, Yamaoka Y, Zhu Q, Matha I, Gao X. A comprehensive sequence and disease correlation analyses for the C-terminal region of CagA protein of Helicobacter pylori. PLoS ONE 4(11), e7736 (2009).
35. Fiorentino M, Ding H, Blanchard TG et al. Helicobacter pylori-induced disruption of monolayer permeability and proinfammatory cytokine secretion in polarized human gastric epithelial cells. Infect. Immun. 81(3), 876-883 (2013).
36. Wroblewski LE, Shen L, Ogden S et al. Helicobacter pylori dysregulation of gastric epithelial tight junctions by urease-mediated myosin II activation. Gastroenterology 136(1), 236-246 (2009).
37. Tan S, Tompkins LS, Amieva MR. Helicobacter pylori usurps cell polarity to turn the cell surface into a replicative niche. PLoS Pathog. 5(5), e1000407 (2009).
38. Borch K, Sjostedt C, Hannestad U et al. Asymptomatic Helicobacter pylori gastritis is associated with increased sucrose permeability. Dig. Dis. Sci. 43(4), 749-753 (1998).
39. Wex T, Monkemuller K, Kuester D et al. Zonulin is not increased in the cardiac and esophageal mucosa of patients with gastroesophageal refux disease. Peptides 30(6), 1082-1087 (2009).
40. Ito T, Kobayashi D, Uchida K et al. Helicobacter pylori invades the gastric mucosa and translocates to the gastric lymph nodes. Lab. Invest. 88(6), 664-681 (2008).
41. Raju D, Hussey S, Ang M et al. Vacuolating cytotoxin and variants in Atg16L1 that disrupt autophagy promote Helicobacter pylori infection in humans. Gastroenterology 142 (5), 1160-1171 (2012).
42. Atherton JC, Cao P, Peek RM Jr et al. Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. Association of specifc vacA types with cytotoxin production and peptic ulceration. J. Biol. Chem. 270(30), 17771-17777 (1995).
43. Sugimoto M, Zali MR, Yamaoka Y. The association of vacA genotypes and Helicobacter pylori-related gastroduodenal diseases in the Middle East. Eur. J. Clin. Microbiol. Infect. Dis. 28(10), 1227-1236 (2009).
44. Sugimoto M, Yamaoka Y. The association of vacA genotype and Helicobacter pylori-related disease in Latin American and African populations. Clin. Microbiol. Infect. 15(9), 835-842 (2009).
45. Mukhopadhyay AK, Kersulyte D, Jeong JY et al. Distinctiveness of genotypes of Helicobacter pylori in Calcutta, India. J. Bacteriol. 182(11), 3219-3227 (2000).
46. Yamaoka Y, Orito E, Mizokami M et al. Helicobacter pylori in North and South America before Columbus. FEBS Lett. 517(1-3), 180-184 (2002).
47. Sugimoto M, Yamaoka Y. The association of vacA genotype and Helicobacter pylori-related disease in Latin American and African populations. Clin. Microbiol. Infect. 15(9), 835-842 (2009).
48. Rhead JL, Letley DP, Mohammadi M et al. A new Helicobacter pylori vacuolating cytotoxin determinant, the intermediate region, is associated with gastric cancer. Gastroenterology 133(3), 926-936 (2007).
49. Hussein NR, Mohammadi M, Talebkhan Y et al. Differences in virulence markers between Helicobacter pylori strains from Iraq and those from Iran: potential importance of regional differences in H. pylori-associated disease. J. Clin. Microbiol. 46(5), 1774-1779 (2008).
50. Basso D, Zambon CF, Letley DP et al. Clinical relevance of Helicobacter pylori cagA and vacA gene polymorphisms. Gastroenterology 135(1), 91-99 (2008).
51. Ogiwara H, Graham DY, Yamaoka Y. vacA i-region subtyping. Gastroenterology 134(4), 1267-1267 (2008).
52. Ferreira RM, Figueiredo C, Bonet C et al. Helicobacter pylori vacA intermediate region genotyping and progression of gastric preneoplastic lesions. Am. J. Gastroenterol. 107(1), 145-146 (2012).
53. Ogiwara H, Sugimoto M, Ohno T et al. Role of deletion located between the intermediate and middle regions of the Helicobacter pylori vacA gene in cases of gastroduodenal diseases. J. Clin. Microbiol. 47(11), 3493-3500 (2009).
54. De Francesco, V, Margiotta M, Zullo A et al. Helicobacter pylori vacA arrangement and related diseases: a retrospective study over a period of 15 years. Dig. Dis. Sci. 54(1), 97-102 (2009).
55. Yamaoka Y, Kwon DH, Graham DY. A M(r) 34, 000 proinfammatory outer membrane protein (oipA) of Helicobacter pylori. Proc. Natl Acad. Sci. USA 97(13), 7533-7538 (2000).
56. Yamaoka Y, Kudo T, Lu H et al. Role of interferon-stimulated responsive element-like element in interleukin-8 promoter in Helicobacter pylori infection. Gastroenterology 126(4), 1030-1043 (2004).
57. Choi IJ, Fujimoto S, Yamauchi K, Graham DY, Yamaoka Y Helicobacter pylori environmental interactions: effect of acidic conditions on H. pylori-induced gastric mucosal interleukin-8 production. Cell Microbiol. 9, 2457-2469 (2007).
58. Lu H, Wu JY, Beswick EJ et al. Functional and intracellular signaling differences associated with the Helicobacter pylori AlpAB adhesin from western and east Asian strains. J. Biol. Chem. 282(9), 6242-6254 (2007).
59. Kudo T, Lu H, Wu JY et al. Pattern of transcription factor activation in Helicobacter pylori-infected Mongolian gerbils. Gastroenterology 132(3), 1024-1038 (2007).
60. Wu JY, Lu H, Sun Y et al. Balance between polyoma enhancing activator 3 and activator protein 1 regulates Helicobacter pylori-stimulated matrix metalloproteinase 1 expression. Cancer Res. 66(10), 5111-5120 (2006).
61. Lu H, Wu JY, Kudo T et al. Regulation of interleukin-6 promoter activation in gastric epithelial cells infected with Helicobacter pylori. Mol. Biol. Cell 16(10), 4954-4966 (2005).
62. Tabassam FH, Graham DY, Yamaoka Y OipA plays a role in Helicobacter pylori-induced focal adhesion kinase activation and cytoskeletal re-organization. Cell Microbiol. 10(4), 1008-1020 (2008).
63. Tabassam FH, Graham DY, Yamaoka Y Helicobacter pylori activate epidermal growth factor receptor-and phosphatidylinositol 3-OH kinase-dependent Akt and glycogen synthase kinase 3beta phosphorylation. Cell Microbiol. 11(1), 70-82 (2009).
64. Choi KD, Kim N, Lee DH et al. Analysis of the 3́ variable region of the cagA gene of Helicobacter pylori isolated in Koreans. Dig. Dis. Sci. 52(4), 960-966 (2007).
65. Kudo T, Lu H, Wu JY et al. Regulation of RANTES promoter activation in gastric epithelial cells infected with Helicobacter pylori. Infect. Immun. 73(11), 7602-7612 (2005).
66. Tabassam FH, Graham DY, Yamaoka Y Paxillin is a novel cellular target for converging Helicobacter pylori-induced cellular signaling. Am. J. Physiol Gastrointest. Liver Physiol. 301(4), G601-G611 (2011).
67. Tabassam FH, Graham DY, Yamaoka Y Helicobacter pylori-associated regulation of forkhead transcription factors FoxO1/3a in human gastric cells. Helicobacter 17(3), 193-202 (2012).
68. Graham DY, Opekun AR, Osato MS et al. Challenge model for Helicobacter pylori infection in human volunteers. Gut 53 (9), 1235-1243 (2004).
69. Yamaoka Y, Kikuchi S, El-Zimaity HM et al. Importance of Helicobacter pylori oipA in clinical presentation, gastric infammation, and mucosal interleukin 8 production. Gastroenterology 123(2), 414-424 (2002).
70. Yamaoka Y, Ojo O, Fujimoto S et al. Helicobacter pylori outer membrane proteins and gastroduodenal disease. Gut 55(6), 775-781 (2006).
71. Ando T, Peek RM, Pride D et al. Polymorphisms of Helicobacter pylori HP0638 refect geographic origin and correlate with cagA status. J. Clin. Microbiol. 40(1), 239-246 (2002).
72. Dossumbekova A, Prinz C, Mages J et al. Helicobacter pylori HopH (OipA) and bacterial pathogenicity: genetic and functional genomic analysis of hopH gene polymorphisms. J. Infect. Dis. 194(10), 1346-1355 (2006).
73. Lehours P, Menard A, Dupouy S et al. Evaluation of the association of nine Helicobacter pylori virulence factors with strains involved in low-grade gastric mucosa-associated lymphoid tissue lymphoma. Infect. Immun. 72(2), 880-888 (2004).
74. Fujimoto S, Olaniyi OO, Arnqvist A et al. Helicobacter pylori BabA expression, gastric mucosal injury, and clinical outcome. Clin. Gastroenterol. Hepatol. 5(1), 49-58 (2007).
75. Lu H, Hsu PI, Graham DY, Yamaoka Y Duodenal ulcer promoting gene of Helicobacter pylori. Gastroenterology 128(4), 833-848 (2005).
76. Hussein NR, Argent RH, Marx CK et al. Helicobacter pylori dupA is polymorphic, and its active form induces proinfammatory cytokine secretion by mononuclear cells. J. Infect. Dis. 202(2), 261-269 (2010).
77. Yamaoka Y. Roles of the plasticity regions of Helicobacter pylori in gastroduodenal pathogenesis. J. Med. Microbiol. 57(Pt 5), 545-553 (2008).
78. Shiota S, Matsunari O, Watada M, Hanada K, Yamaoka Y. Systematic review and meta-analysis: the relationship between the Helicobacter pylori dupA gene and clinical outcomes. Gut Pathog. 2(1), 13 (2010).
79. Takahashi A, Shiota S, Matsunari O et al. Intact long-type dupA as a marker for gastroduodenal diseases in Okinawan subpopulation, Japan. Helicobacter 18(1), 66-72 (2012).
80. Jung SW, Sugimoto M, Shiota S, Graham DY, Yamaoka Y. The intact dupA cluster is a more reliable Helicobacter pylori virulence marker than dupA alone. Infect. Immun. 80(1), 381-387 (2012).
81. Kersulyte D, Lee W, Subramaniam D et al. Helicobacter pylori's plasticity zones are novel transposable elements. PLoS ONE 4(9), e6859 (2009).
82. Fischer W, Windhager L, Rohrer S et al. Strain-specifc genes of Helicobacter pylori: genome evolution driven by a novel type IV secretion system and genomic island transfer. Nucleic Acids Res. 38(18), 6089-6101 (2010).
83. Kawai M, Furuta Y, Yahara K et al. Evolution in an oncogenic bacterial species with extreme genome plasticity: Helicobacter pylori east Asian genomes. BMC Microbiol. 11, 104 (2011).
84. McClain MS, Shaffer CL, Israel DA, Peek RM Jr, Cover TL. Genome sequence analysis of Helicobacter pylori strains associated with gastric ulceration and gastric cancer. BMC Genomics 10, 3 (2009).
85. McNamara D. Helicobacter pylori infection and the pathogenesis of gastric cancer: a paradigm for host-bacterial interactions 40(7), 504-509 (2008).
86. Kennemann L, Didelot X, Aebischer T et al. Helicobacter pylori genome evolution during human infection. Proc. Natl Acad. Sci. USA 108(12), 5033-5038 (2011).
87. Ubukata H, Nagata H, Tabuchi T et al. Why is the coexistence of gastric cancer and duodenal ulcer rare? Examination of factors related to both gastric cancer and duodenal ulcer. Gastric Cancer 14(1), 4-12 (2011).
88. Fukase K, Kato M, Kikuchi S et al. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet 372(9636), 392-397 (2008).
89. Kim JJ, Tao H, Carloni E et al. Helicobacter pylori impairs DNA mismatch repair in gastric epithelial cells. Gastroenterology 123(2), 542-553 (2002).
90. Matsumoto Y, Marusawa H, Kinoshita K et al. Helicobacter pylori infection triggers aberrant expression of activation-induced cytidine deaminase in gastric epithelium. Nat. Med. 13(4), 470-476 (2007).
91. Toller IM, Neelsen KJ, Steger M et al. Carcinogenic bacterial pathogen Helicobacter pylori triggers DNA double-strand breaks and a DNA damage response in its host cells. Proc. Natl Acad. Sci. USA 108(36), 14944-14949 (2011).
92. Ushijima T, Hattori N. Molecular pathways: involvement of Helicobacter pylori-triggered infammation in the formation of an epigenetic feld defect, and its usefulness as cancer risk and exposure markers. Clin. Cancer Res. 18(4), 923-929 (2012).
93. Salama NR, Hartung ML, Muller A. Life in the human stomach: persistence strategies of the bacterial pathogen Helicobacter pylori. Nat. Rev. Microbiol. 11(6), 385-399 (2013).